TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA

Bmi1 is a master regulatory stem cell self-renewal gene and epigenetic regulator that presents a downstream target of developmental pathways active during the genesis of the childhood brain tumor medulloblastoma (MB). Here, we describe Bmi1 as a novel therapeutic target for the treatment of recurren...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bakhshinyan, David, Garg, Neha, Manoranjan, Branavan, Venugopal, Chitra, Hallett, Robin, Wang, Xin, Kameda-smith, Michelle, Adile, Ashley, Ramaswamy, Vijay, Davis, Thomas, Weetall, Marla, Moon, Young-choon, Mitra, Siddhartha, Cho, Yoon-Jae, Taylor, Michael, Singh, Sheila
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475198/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.225
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados